checkAd

     1199  0 Kommentare Dermatological Drugs Market Forecast 2017-2027 - Seite 2

    • Two interviews conducted by Visiongain with experts in the dermatological drugs market:
    • Interview with Dr Michael Siegel, Vice President of Research Programs at National Psoriasis Foundation.
    • Interview with Guillaume Clement, Executive Vice President, Region EUROPE+, LEO Pharma.

    • Our study discusses the selected leading companies that are the major players in the dermatological drugs market:
    • Galderma (Nestle Skin Health S.A.)
    • Johnson & Johnson
    • AbbVie
    • GlaxoSmithKline (GSK)
    • Pfizer
    • LEO Pharma

    Our new report discusses issues and events affecting the dermatological drugs market:
    • Highly fragmented and competitive market with significant variations in different geographic regions.
    • Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities.
    • Future paradigm-shifting pipeline products.
    • Patent expirations.
    • Launches of new drug categories.
    • Biosimilars approvals, Biosimilars interchangeability, Biosimilars guidance.

    Visiongain's study is intended for anyone requiring commercial analyses for the dermatological drugs market. You find data, trends and predictions.

    Buy our report today Dermatological Drugs Market Forecast 2017-2027: Psoriasis, Skin Infection, Acne, Dermatitis, Humira, Stelara, Enbrel, Remicade, Taltz, Cosentyx, Cubicin, Canesten, Epiduo, Bepanthen, Elocon, Galderma, Johnson & Johnson, AbbVie, GSK, Pfizer, LEO Pharma.

    To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

    Or click on https://www.visiongain.com/Report/1929/Dermatological-Drugs-Market-Forecast-2017-2027

    Companies and Organizations Mentioned in the Report:  

    Abbott

    AbbVie

    Actavis

    AET BioTech

    Alkem Laboratories

    Allergan

    Almirall

    Amgen

    Anacor

    Ascend Therapeutics

    Astellas

    Aurovindo

    Barr Labs

    Bayer

    Betta Pharmaceuticals

    Biocon/Mylan

    Biofrontera

    Biogen

    Biovail Laboratories

    BioXpress Therapeutics

    Boehringer Ingelheim

    Bristol-Myers Squibb

    Brazilian Society of Dermatology

    Cadila Healthcare

    Can-Fite BioPharma

    Cassiopea SpA

    Celgene

    Celltrion

    Cempra

    Cipher Pharmaceuticals

    Seite 2 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Dermatological Drugs Market Forecast 2017-2027 - Seite 2 LONDON, July 25, 2017 /PRNewswire/ - Psoriasis, Skin Infection, Acne, Dermatitis, Humira, Stelara, Enbrel, Remicade, Taltz, Cosentyx, Cubicin, Canesten, Epiduo, Bepanthen, Elocon, Galderma, Johnson & Johnson, AbbVie, GSK, Pfizer, LEO Pharma. The …